SARS-CoV-2-vaccineinduceret immuntrombose og trombocytopeni
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 958 KB, PDF-dokument
Vaccine-induced immune thrombosis and thrombocytopenia (VITT) is a new syndrome, which has emerged after introduction of the adenovirus vector-based COVID-19 vaccines ChAdOx1 nCoV-19 og Ad26.COV2-SVITT is characterised by venous thrombosis at unusual, and often multiple localisations, especially including cerebral venous sinus thrombosis. Besides, bleeding manifestations often occur. Biochemically, VITT is characterised by thrombocytopaenia and elevated fibrin d-dimer. VITT is a rapidly progressing and potentially life-threatening syndrome where rapid diagnosis and treatment are essential as argued in this review.
Bidragets oversatte titel | SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia |
---|---|
Originalsprog | Dansk |
Artikelnummer | V05210473 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 183 |
Udgave nummer | 29 |
Antal sider | 8 |
ISSN | 0041-5782 |
Status | Udgivet - 19 jul. 2021 |
- COVID-19, COVID-19 Vaccines, ChAdOx1 nCoV-19, Humans, SARS-CoV-2, Thrombocytopenia/chemically induced, Thrombosis, Vaccines
Forskningsområder
Links
- https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2021-07/v05210473_web.pdf
Forlagets udgivne version
ID: 288276686